Dr Krishna Ravindranathan is a serial entrepreneur. He founded and was the CEO Genome Shield based in New Haven CT, before moving onto his present role as founder and CEO of Mind Pharmaceuticals Corp in 2024. Prior to his entrepeneur career, he was a Postdoc at Yale Pharmacology, where he worked on receptor tyrosine kinase signaling and also at Yale Chemistry where his research was in computer aided drug design.